J&J | JNJ - Pre Tax Profit


J&J reported $7.82B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Abbott USD 2.39B 27M Mar/2026
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Baxter International USD -756M 877M Dec/2025
Bayer EUR -3.37B 2.21B Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Boston Scientific USD 700M 238M Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
CONMED USD 29.25M 24.98M Dec/2025
Cooper Companies USD 192.2M 75.4M Dec/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Globus Medical USD 169.23M 25.24M Dec/2025
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.45B 1.04B Mar/2026
Merck USD 3.42B 3.32B Dec/2025
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Vertex Pharmaceuticals USD 1.25B 78.1M Mar/2026
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025
Zoetis USD 761M 126M Dec/2025